1. Australia Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Elixinol Wellness Limited

Elixinol Wellness Limited

EXL.AX
Elixinol Wellness LimitedAU flagAustralian Securities Exchange
0.01
AUD
+0.00
- -
1.30MMarket Cap
Elixinol Wellness Limited
EXL.AX
(Australian Securities Exchange)

Recent

price

0.01

P/E

ratio

- -

div

yld

- -

ROIC.AI

2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
- -
1.76
1.1
0.52
0.18
0.14
0.11
0.1
0.06
Revenue per Share
- -
-0.04
-3.38
-3.62
-0.34
-0.21
-0.1
-0.01
-0.02
Basic EPS, GAAP
- -
-0.21
-0.45
-0.01
-0.01
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
6.45
4.13
0.93
0.2
-0.01
-0.05
- -
-0.01
Book Value per Share
- -
-0.97
2.94
1.2
0.37
0.18
0.05
0.02
0.01
Tangible Book Value per Share
- -
21
25
29
51
51
76
155
256
Basic Weighted Avg Shares
- -
37
27
15
9
7
8
15
16
Sales/Revenue/Turnover
- -
-2.62
-87.43
-168.73
-167.16
-141.77
-78.15
-34.14
-38.61
Operating Margin (%)
- -
1
2
3
1
1
1
1
1
Depreciation Expense
- -
-1
-83
-105
-17
-11
-8
-2
-6
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
-2.32
-306.6
-696.24
-182.32
-149.84
-90.78
-11.51
-35.48
Profit Margin (%)
21
50
72
30
15
6
4
2
-1
Working Capital
- -
- -
4
2
2
1
- -
1
- -
LT Debt
99
144
111
36
19
9
6
10
7
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-0.73
-70.08
-162.67
-92.87
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-19.69%
-25.67%
Free Cash Flow
- -
51.21%
68.33%
Net Income, GAAP
- -
-1.65%
219.4%
Sales/Revenue/Turnover
- -
7.9%
3.64%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
8
2024
- -
- -
- -
- -
15
2025
- -
- -
- -
- -
16

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
-0.1
2024
- -
- -
- -
- -
-0.01
2025
- -
- -
- -
- -
-0.02

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
Extrawell Pharmaceutical Holdings Limited (0858.HK)
Blau Farmacêutica S.A. (BLAU3.SA)
Poko Innovations Inc. (POKO.CN)
Siegfried Holding AG (0QQO.L)
Leef Brands Inc. (ICNAF)
Alivus Life Sciences Limited (ALIVUS.BO)
Business
Elixinol Wellness Limited functions as a dedicated health and wellness enterprise, engaged in the creation and supply of a broad spectrum of plant-based and hemp-derived products. These offerings include nutraceuticals, advanced skincare, and various food items. The company showcases a comprehensive brand portfolio featuring Elixinol for its cannabidiol (CBD) range, alongside Hemp Foods Australia, Mt Elephant, The Healthy Chef, and Field Day, addressing human nutrition, overall wellness, and pet supplementation needs. Its distribution network extends across Australia, the Americas, Europe, and other international territories, leveraging grocery, wholesale, and expanding e-commerce platforms. Founded in 2017, the company, formerly known as Elixinol Global Limited, adopted its current name, Elixinol Wellness Limited, in May 2021. Based in South Melbourne, Australia, it recently reported an 81% surge in group revenue for 2024, attributed to strategic acquisitions and operational enhancements, with further plans for growth in e-commerce and the healthy snacking sector throughout 2025.